10-QPeriod: Q1 FY2025

3M CO Quarterly Report for Q1 Ended Mar 31, 2025

Filed April 22, 2025For Securities:MMM

Summary

3M Company reported a slight decrease in net sales for the first quarter of 2025 compared to the prior year, with reported sales of $5.95 billion versus $6.02 billion in Q1 2024. However, when adjusted for currency translation and divestitures, organic sales showed a modest increase. The company demonstrated improved profitability, with operating income rising to $1.25 billion from $1.15 billion and earnings per diluted share from continuing operations increasing significantly to $2.04 from $1.27. This improvement was driven by factors including lower restructuring costs, productivity gains, and a favorable year-over-year change in the valuation of its retained Solventum ownership stake. Despite the overall sales decline, certain segments showed resilience and growth, particularly Safety and Industrial. The company continues to navigate substantial legal and environmental liabilities, most notably those related to PFAS, which had a significant impact on 'Other Expense (Income), net' and are an ongoing area of focus and potential financial exposure. The company's liquidity remains strong, with substantial cash reserves and access to credit facilities, enabling continued investment in operations, share repurchases, and dividend payments.

Financial Highlights

52 data points
Beta

Revenue

$5.95B

41.6% Gross Margin

Net Income

$1.12B

18.7% Net Margin

EPS (Diluted)

$2.04

Total Assets

$39.95B

Cash & Equivalents

$6.33B

Free Cash Flow

-$315.00M

Financial Statements
Beta
Revenue$5.95B
Cost of Revenue$3.48B
Gross Profit$2.48B
SG&A Expenses$945.00M
Operating Expenses$4.71B
Operating Income$1.25B
Interest Expense$110.00M
Net Income$1.12B
EPS (Basic)$2.05
EPS (Diluted)$2.04
Shares Outstanding (Basic)543.80M
Shares Outstanding (Diluted)547.70M

Key Highlights

  • 1Net sales slightly decreased to $5.95 billion from $6.02 billion year-over-year, but organic sales showed a modest improvement of 0.3% when adjusted for currency and divestitures.
  • 2Earnings per diluted share from continuing operations saw a substantial increase to $2.04 from $1.27 in the prior year's quarter.
  • 3Operating income improved to $1.25 billion, up from $1.15 billion in Q1 2024, with operating margin expanding to 20.9%.
  • 4The Safety and Industrial segment reported a 0.5% increase in sales and a 5.9% rise in operating income, demonstrating segment strength.
  • 5The Transportation and Electronics segment experienced a sales decline of 5.4% due to headwinds from PFAS manufactured products and softer auto demand, though organic sales showed a slight increase when adjusted for special items.
  • 6The company reported significant progress in managing its legal liabilities, with the Combat Arms Earplugs (CAE) settlement seeing over 99% claimant participation and the Public Water Systems (PWS) settlement making substantial payments.
  • 73M maintained strong liquidity with $7.0 billion in cash, cash equivalents, and marketable securities as of March 31, 2025.

Frequently Asked Questions

For the first quarter of 2025, 3M reported net sales of $5.95 billion, a slight decrease of 1.0% compared to $6.02 billion in the first quarter of 2024. On an organic basis, excluding the impact of foreign currency translation and divestitures, sales decreased by 0.3%. Adjusted sales, which exclude certain special items, increased by 0.8% year-over-year.

Profitability improved significantly. Operating income increased to $1.25 billion in Q1 2025 from $1.15 billion in Q1 2024. This resulted in an improved operating margin of 20.9%, up from 19.1% in the prior year. Earnings per diluted share from continuing operations rose substantially to $2.04 from $1.27 year-over-year.

The company continues to incur significant costs and has made substantial payments related to PFAS liabilities. While the PWS settlement for public water systems has a high claimant participation rate, and the CAE settlement is progressing, these ongoing legal and environmental matters represent substantial accrued liabilities and future payment obligations. The 'Other Expense (Income), net' line item shows a year-over-year benefit of $343 million due to the change in value of 3M's retained ownership interest in Solventum, but the PFAS-related liabilities and settlements, alongside other litigation, are major financial considerations for the company.

The separation of Solventum (formerly the Health Care business) as of April 1, 2024, impacted comparability. While Solventum's historical results are now reported as discontinued operations, the separation itself created some dis-synergies and transition costs. However, the company also benefited from a $343 million year-over-year positive impact on 'Other Expense (Income), net' related to the change in value of 3M's retained ownership interest in Solventum.